期刊
BRITISH JOURNAL OF CANCER
卷 127, 期 8, 页码 1403-1410出版社
SPRINGERNATURE
DOI: 10.1038/s41416-022-01868-6
关键词
-
类别
资金
- AiF GmbH
- BMBF, Germany
- Werner Otto Stiftung
- Projekt DEAL
Human papilloma virus (HPV) is an infectious carcinogenic agent, and almost all cervical cancers are positive for high-risk HPV. Despite the introduction of HPV vaccines in many countries, most females worldwide are still not vaccinated. The use of blood-based liquid biopsy approaches, particularly cell-free DNA (cfDNA), has shown great potential in early detection and monitoring of cervical cancer.
Human papilloma virus (HPV) is an infectious carcinogenic agent. Nearly all cervical cancers are positive for one of the high-risk HPV subtypes. Although the introduction of the HPV vaccines in many countries have shown tremendous positive effects on the incidence of both cervical intraepithelial lesions (CIN) and invasive cancer, the large majority of females worldwide are still not vaccinated. Patients with diagnosed high-grade CIN need a lifelong close monitoring of possible relapse or development of invasive cancer. Different blood-based liquid biopsy approaches have shown great promise as an easily obtainable minimally invasive tool for early detection and monitoring of disease. Among the different liquid biopsy approaches the clinical relevance of cell-free DNA (cfDNA) in cervical cancer has been best investigated. In cervical cancer, the DNA fragments can be of both, human as well as viral origin. Thus, the mutation and methylation status of genes related to carcinogenesis as well as the HPV status can be analysed in plasma from cervical cancer patients. This review describes recent advances in different cfDNA approaches for early detection and monitoring of cervical cancer and its precursor lesions.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据